Breaking News Instant updates and real-time market news.

HQY

HealthEquity

$57.90

-1.49 (-2.51%)

 07:15
03/20/18
 03/20
07:15
 03/20/18
07:15

HealthEquity price target raised to $70 from $60 at SunTrust

SunTrust analyst Sandy Draper raised his price target on HealthEquity to $70 after the company's Q4 earnings beat and raised FY19 outlook. Draper notes that while there is limited upside opportunity for revenue in the current fiscal year due to "seasonality of open enrollment", his bullish view is driven by the company's "market share grabbing and margin-expanding revenue growth" over the longer term within a positive market environment. The analyst keeps his Buy rating on HealthEquity.
HQY HealthEquity
$57.90

-1.49 (-2.51%)

02/08/18
CANT
02/08/18
NO CHANGE
Target $60
CANT
Overweight
HealthEquity selloff yesterday overdone, says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper views the pullback yesterday in shares of HealthEquity as overdone. The analyst says the company's "light" fiscal 2019 revenue guidance is not concerning as he still expects 22.9% growth. He sees no fundamental reason for the share weakness and reiterates an Overweight rating on HealthEquity with a $60 price target.
01/04/18
SBSH
01/04/18
INITIATION
Target $69
SBSH
Buy
HealthEquity initiated with a Buy at Citi
Citi analyst Stephanie Davis started HealthEquity with a Buy rating and $69 price target. The analyst sees a "compelling entry point" following the recent pullback in shares.
09/26/17
OPCO
09/26/17
NO CHANGE
OPCO
Graham-Cassidy health bill would be positive for HealthEquity, says Oppenheimer
Oppenheimer analyst Mohan Naidu notes that he does not know if the Graham-Cassidy health reform bill will go through. The analyst believes its passage would be a clear win for HealthEquity (HQY), as it would nearly double HSA contribution limits. On HMS Holdings (HMSY), however, passage likely hurts sentiment on possible slowdown in Medicaid spending and reshuffle in funding allocation but unlikely to impact numbers near-term, he contended.
03/31/17
03/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Market Perform at Wells Fargo. 2. Amazon.com (AMZN) was initiated with a Buy at Loop Capital while Alphabet (GOOG, GOOGL) was initiated with a Hold. 3. Dermira (DERM) initiated with a Buy at Mizuho. 4. TSYS (TSS) initiated with a Buy at Guggenheim. 5. HealthEquity (HQY) initiated with an Overweight at Cantor. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.